Tell your doctor if you have or have had any medical conditions, including: a disease of the spinal cord or folate-deficient megaloblastic anaemia (a type of anaemia caused by the deficiency of another vitamin called folic acid)
Also like capsules, the principal challenge to the successful absorption of peptides by nasal spray through the nasal or lung mucosa is the limited bioavailability
This was Citius second try for FDA approval, after the regulator rejected Lymphir in July 2023, outlining the need for enhanced product resting requirements. In its resubmitted data package, the company included findings from the from the Phase III Study 302 trial, where treatment with the drug led to an objective response rate of 36.2%, with 8.7% reaching complete response
In principle, etomoxir treatment could alleviate NHK-dependent ER stress by reducing protein synthesis
June 25 Product: AbbVies ABBV-951 Indication: Parkinsons disease For the second time in as many years, the FDA declined to approve AbbVies experimental Parkinsons treatment ABBV-951, citing issues with a third-party manufacturer